Firms
Third Rock Ventures
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
No team members on record yet.
Co-investing
ARCH Venture Partners
Seaport Therapeutics$225M · 2024-10-21Rapport$100M · 2023
Sage Therapeutics$37M · 2013-09
bluebird bio$60M · 2012-07-25Agios$78M · 2011
Agios$8M · 2010
Agios Pharmaceuticals$33M · 2008-07-07Agios$15M · 2008
Sage Therapeutics$— · Unknown date
Bain Capital
Merida Biosciences$121M · 2026-08-25
Syremis Therapeutics$165M · Unknown date
Nurix$120M · Unknown date
Syremis Therapeutics$165M · Unknown date
Nurix Therapeutics$120M · Unknown date
Wellington Management
Asher Bio$55M · 2024
Asher Bio$108M · 2021-09-01
Nurix$120M · Unknown date
Nurix Therapeutics$120M · Unknown date
Boxer Capital
Asher Bio$55M · 2024
Nurix$120M · Unknown date
Nurix Therapeutics$120M · Unknown date
Foresite Capital
Nurix$120M · Unknown date
Nurix Therapeutics$120M · Unknown date
GV
Merida Biosciences$121M · 2026-08-25
Syremis Therapeutics$165M · 2025-12-18
The Column Group
Nurix$120M · Unknown date
Nurix Therapeutics$120M · Unknown date
Accelmed Partners
Corvia Medical$55M · 2025-06-17
Alexandria Venture Investments
Asher Bio$108M · 2021-09-01
Alphabet Inc.
Syremis Therapeutics$165M · Unknown date
AstraZeneca
Asher Bio$55M · 2024
Bain Capital Life Sciences
Syremis Therapeutics$165M · 2025-12-18
Bristol Myers Squibb
Asher Bio$55M · 2024
Canada Pension Plan Investment Board
Seaport Therapeutics$225M · 2024-10-21
Deerfield
bluebird bio$60M · 2012-07-25
Dexcel Pharma
Syremis Therapeutics$165M · 2025-12-18
Forbion
bluebird bio$60M · 2012-07-25
General Atlantic
Seaport Therapeutics$225M · 2024-10-21
General Catalyst
Corvia Medical$55M · 2025-06-17
Hemant Taneja
Corvia Medical$55M · 2025-06-17
Illumina Ventures
Corvia Medical$55M · 2025-06-17
Johnson & Johnson Innovation
Rapport$100M · 2023
LightspeedAbata Therapeutics$95M · 2021
Logos Capital
Asher Bio$108M · 2021-09-01
Mission BioCapital
Asher Bio$108M · 2021-09-01
Perceptive Xontogeny Venture Fund
Merida Biosciences$121M · 2026-08-25
Pictet
Syremis Therapeutics$165M · 2025-12-18
PureTech Health
Seaport Therapeutics$225M · 2024-10-21
QVT Family Office
Syremis Therapeutics$165M · 2025-12-18
Samsara BioCapitalAbata Therapeutics$95M · 2021
Sanofi Ventures
bluebird bio$60M · 2012-07-25
Sofinnova Partners
Seaport Therapeutics$225M · 2024-10-21
T. Rowe Price
Seaport Therapeutics$225M · 2024-10-21
The Invus Group, LLCAbata Therapeutics$95M · 2021
Wisdom VenturesRapport$100M · 2023
